Epidemiology of DSM-5 drug use disorder results from the national epidemiologic survey on alcohol and related conditions-III

JAMA Psychiatry

Volumn 73, Issue 1, 2016, Pages 39-47

  Grant, Bridget F ^a   Saha, Tulshi D ^a   June Ruan, W ^a   Goldstein, Risë B ^a   Patricia Chou, S ^a   Jung, Jeesun ^a   Zhang, Haitao ^a   Smith, Sharon M ^a   Pickering, Roger P ^a   Huang, Boji ^a   Hasin, Deborah S ^b,c  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b Columbia University ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; AMPHETAMINE; CANNABIS; DIAMORPHINE; KETAMINE; PSYCHEDELIC AGENT; SEDATIVE AGENT; SOLVENT; TRANQUILIZER;

ADULT; AGED; AMERICAN INDIAN; ANTISOCIAL PERSONALITY DISORDER; ARTICLE; BIPOLAR I DISORDER; BORDERLINE STATE; COCAINE DEPENDENCE; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DSM-5; DYSTHYMIA; EDUCATIONAL STATUS; FEMALE; GENERALIZED ANXIETY DISORDER; HUMAN; INCOME; INHALANT ABUSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; METHAMPHETAMINE DEPENDENCE; MIDDLE AGED; OPIATE ADDICTION; OUTCOME ASSESSMENT; PANIC; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; SCHIZOTYPAL PERSONALITY DISORDER; SOCIAL PHOBIA; SOCIOECONOMICS; UNITED STATES; YOUNG ADULT; ADOLESCENT; AMPHETAMINE DEPENDENCE; BIPOLAR DISORDER; BORDERLINE PERSONALITY DISORDER; COCAINE-RELATED DISORDERS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTHYMIC DISORDER; HEROIN DEPENDENCE; MARIJUANA ABUSE; OPIOID-RELATED DISORDERS; PERSONALITY DISORDERS; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS;

ADOLESCENT; ADULT; AGED; AMPHETAMINE-RELATED DISORDERS; ANTISOCIAL PERSONALITY DISORDER; BIPOLAR DISORDER; BORDERLINE PERSONALITY DISORDER; COCAINE-RELATED DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DYSTHYMIC DISORDER; FEMALE; HEROIN DEPENDENCE; HUMANS; INHALANT ABUSE; MALE; MARIJUANA ABUSE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PERSONALITY DISORDERS; PREVALENCE; SCHIZOTYPAL PERSONALITY DISORDER; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; SUBSTANCE-RELATED DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 84954143197     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.2132     Document Type: Article

References (62)

1. OBrien CP, Charney DS, Lewis L, et al. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry. 2004;56 (10):703-713.
2. Kessler RC. The epidemiology of dual diagnosis. Biol Psychiatry. 2004;56(10):730-737.
3. Swendsen JD, Merikangas KR. The comorbidity of depression and substance use disorders. Clin Psychol Rev. 2000;20(2):173-189.
4. Degenhardt L, HallW. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810): 55-70.
5. Nock MK, Borges G, Bromet EJ, et al. Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry. 2008;192(2):98-105.
6. Yuodelis-Flores C, Ries RK. Addiction and suicide: a review. Am J Addict. 2015;24(2):98-104.
7. ComptonWMIII, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry. 2003;160(5):890-895.
8. United States Department of Justice, National Drug Intelligence Center. The Economic Impact of Illicit Drug Use on American Society.Washington, DC: US Department of Justice; 2011.
9. Berg CJ, Stratton E, Schauer GL, et al. Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win. Subst Use Misuse. 2015;50(1):79-89.
10. Gallup. Majority continues to support pot legalization in US. http://www.gallup.com/poll/179195/majority-continues-support-pot-legalization.aspx. Published November 6, 2014. Accessed July 17, 2015.
11. Hasin DS, WallM, Keyes KM, et al. State medical marijuana laws and adolescent marijuana use in the United States: 1991-2014. Lancet Psychiatry. 2015; 2(7):601-608.
12. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219-2227.
13. Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;13(5):401-435.
14. Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15(3)(suppl):ES67-ES92.
15. Warner M, Hedegaard H, Chen L-H. Trends in Drug-Poisoning Deaths Involving Opioid Analgesics and Heroin: United States. Atlanta, GA: Centers for Disease Control and Prevention; 2012.
16. Compton WM, Gfroerer J, Conway KP, Finger MS. Unemployment and substance outcomes in the United States 2002-2010. Drug Alcohol Depend. 2014;142(1):350-353.
17. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64(5):566-576.
18. Goldstein RB, Chou SP, Smith SM, et al. Nosologic comparisons of DSM-IV and DSM-5 alcohol and drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. J Stud Alcohol Drugs. 2015; 76(3):378-388.
19. Compton WM, Dawson DA, Goldstein RB, Grant BF. Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol. Drug Alcohol Depend. 2013;132(1-2):387-390.
20. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
22. Hasin DS, OBrien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834-851.
23. Tiffany ST, Friedman L, Greenfield SF, Hasin DS, Jackson R. Beyond drug use: a systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction. 2012;107(4):709-718.
24. Grant BF, AmsbaryM, Chu A, et al. Source and Accuracy Statement: National Epidemiologic Survey on Alcohol and Related Conditions-III (NESARC-III). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2014.
25. Bureau of the Census. American Community Survey, 2012. Suitland, MD: Bureau of the Census; 2013.
26. Grant BF, Goldstein RB, Saha TD, et al. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015; 72(8):757-766.
27. Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health-Detailed Tables. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
28. Centers for Disease Control and Prevention. Summary Health Statistics for US Adults: National Health Interview Survey, 2012. Hyattsville, MD: National Center for Health Statistics; 2014.
29. Grant BF, Goldstein RB, Chou SP, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition Version (AUDADIS-5). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2011.
30. Grant BF, Goldstein RB, Smith SM, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): reliability of substance use and psychiatric disorder modules in a general population sample. Drug Alcohol Depend. 2015;148(1):27-33.
31. Hasin DS, Aivadyan C, Greenstein E, Grant BF. Psychiatric Research Interview for Substance Use and Mental Disorders, Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (PRISM-5) Version. New York, NY: Columbia University, Department of Psychiatry; 2011.
32. Hasin DS, Greenstein E, Aivadyan C, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-Appraisal in a general population sample. Drug Alcohol Depend. 2015;148(1):40-46.
33. Hasin DS, Shmulewitz D, Stohl M, et al. Procedural validity of the AUDADIS-5 depression, anxiety and post-Traumatic stress disorder modules: substance abusers and others in the general population. Drug Alcohol Depend. 2015;152 (1):246-256.
34. Gandek B, Ware JE Jr, Aaronson NK, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1149-1158.
35. Research Triangle Institute. SUDAAN Language Manual, Release 11.0. Research Triangle Park, NC: Research Triangle Institute; 2012.
36. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
37. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication [published correction appears in Arch Gen Psychiatry. 2005;62(7):768].
38. Arch Gen Psychiatry. 2005;62(6):593-602.
39. Chou SP, Goldstein RB, Smith SM, et al. The epidemiology of DSM-5 nicotine use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. J Clin Psychiatry. In press.
40. Degenhardt L, HallW, Lynskey M. Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction. 2001;96(11): 1603-1614.
41. Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69(4):533-545.
42. Pulay AJ, Stinson FS, Dawson DA, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Prim Care Companion J Clin Psychiatry. 2009;11(2):53-67.
43. Grant BF, Goldstein RB, Chou SP, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14 (11):1051-1066.
44. Agrawal A, Lynskey MT. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction. 2008;103(7): 1069-1081.
45. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60(9):929-937.
46. Agrawal A, Verweij KJ, Gillespie NA, et al. The genetics of addiction-A translational perspective. Transl Psychiatry. 2012;2:e140.
47. National Institute on Drug Abuse. Principles of Drug Addiction Treatment. Bethesda, MD: National Institute on Drug Abuse; 2012.
48. Allsop SJ, Stevens CF. Evidence-based practice or imperfect seduction? developing capacity to respond effectively to drug-related problems. Drug Alcohol Rev. 2009;28(5):541-549.
49. Room R. Stigma, social inequality and alcohol and drug use. Drug Alcohol Rev. 2005;24(2):143-155.
50. Babor TF, Kadden RM. Screening and interventions for alcohol and drug problems in medical settings: what works? J Trauma. 2005;59(3 suppl):S80-S87; discussion S94-S100.
51. McLellan AT, Meyers K. Contemporary addiction treatment: a review of systems problems for adults and adolescents. Biol Psychiatry. 2004; 56(10):764-770.
52. National Center on Addiction and Substance Abuse at Columbia University. Addiction Medicine: Closing the Gap Between Science and Practice. New York, NY:National Center on Addiction and Substance Abuse at Columbia University; 2012.
53. Volkow ND. Its time for addiction science to supersede stigma. https://www.sciencenews.org/article/it%E2%80%99s-Time-Addiction-science -supersede-stigma. Published October 24, 2008. Accessed April 17, 2015.
54. Saitz R. Screening and brief intervention for unhealthy drug use: little or no efficacy. Front Psychiatry. 2014;5:121.
55. Young MM, Stevens A, Galipeau J, et al. Effectiveness of brief interventions as part of the Screening, Brief Intervention and Referral to Treatment (SBIRT) model for reducing the nonmedical use of psychoactive substances: a systematic review. Syst Rev. 2014;3:50.
56. Hingson R, Compton WM. Screening and brief intervention and referral to treatment for drug use in primary care: back to the drawing board. JAMA. 2014;312(5):488-489.
57. Johnson BA, ed. Addiction Medicine: Science and Practice. New York, NY: Springer; 2011.
58. Substance Abuse and Mental Health Services Administration. Leading Change: A Plan for SAMHSAs Roles and Actions 2011-2014. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2011.
59. Livingston JD, Milne T, FangML, Amari E. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107(1):39-50.
60. Polcin DL. Addiction science advocacy: mobilizing political support to influence public policy. Int J Drug Policy. 2014;25(2):329-331.
61. Compton WM, Dawson D, Duffy SQ, Grant BF. The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States. Am J Psychiatry. 2010;167(4):473-474.
62. Tourangeau R, Yan T. Sensitive questions in surveys. Psychol Bull. 2007;133(5):859-883.